Publications
5674 Results
- Journal / Conference
- PLOS ONE 10(3):e0117574
- Year
- 2015
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID25799011
- PMC
- PMC4370655
- Study Number(s)
- S0000
Vitamin D metabolic pathway genes and pancreatic cancer risk
- Journal / Conference
- Journal of Clinical Oncology 33(1):13-21
- Year
- 2015
- Research Committee(s)
- Breast
- PMID
- PMID25092775
- PMC
- PMC4268249
- Study Number(s)
- CTSU/C40603
Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant weekly paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II-III triple-negative breast cancer: CALGB 40603 (Alliance)
- Journal / Conference
- Cancer Causes and Control 26(1):35-44
- Year
- 2015
- Research Committee(s)
- Cancer Control
- PMID
- PMID25359302
- PMC
- PMC4282945
- Study Number(s)
- SWOG-9217
Prospective study of human herpes virus type 8 serostatus and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial
- Journal / Conference
- Clinical Lung Cancer Sep;16(5):340-347
- Year
- 2015
- Research Committee(s)
- Lung
- PMID
- PMID25703100
- PMC
- PMC4497941
- Study Number(s)
- S0533
A pilot trial of cisplatin/etoposide/radiotherapy followed by consolidation docetaxel and the addition of bevacizumab (NSC-704865) in patients with inoperable locally advanced stage III non-small cell lung cancer: SWOG S0533
- Journal / Conference
- New England Journal of Medicine, Mar 5; 372(10):923-932
- Year
- 2015
- Research Committee(s)
- Breast
- PMID
- PMID25738668
- PMC
- PMC4405231
- Study Number(s)
- S0230
Goserelin for Ovarian Protection during Breast-Cancer Adjuvant Chemotherapy
- Journal / Conference
- Journal of the National Cancer Institute, 2014 Nov 27;107(1):345. doi: 10.1093/jnci/dju345; Print Jan 2015 Jan
- Year
- 2015
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID25432409
- PMC
- PMC4271076
- Study Number(s)
- C89803
Aspirin and COX-2 inhibitor use in patients with stage III colon cancer.
- Journal / Conference
- Journal of Clinical Oncology Jun 10;33(17):1936-1942
- Year
- 2015
- Research Committee(s)
- Lymphoma
- PMID
- PMID25897153
- PMC
- PMC4451176
- Study Number(s)
- E2496
Randomized phase III trial comparing ABVD plus radiotherapy with the Stanford V regimen in patients with stage I or II locally extensive, bulky mediastinal hodgkins lymphoma: a subset analysis of the North American Intergroup E2496 trial
- Journal / Conference
- Blood Feb 5;125(6):992-998
- Year
- 2015
- Research Committee(s)
- Lymphoma
- PMID
- PMID25422100
- PMC
- PMC4319239
- Study Number(s)
- S0016, S9800, S9911
Elevated serum levels of IL-2R, IL-1RA and CXCL9 are associated with a poor prognosis in follicular lymphoma
- Journal / Conference
- Journal of Clinical Oncology May 10;33(14):1601-1608
- Year
- 2015
- Research Committee(s)
- Genitourinary
- PMID
- PMID25847934
- PMC
- PMC4417730
- Study Number(s)
- S0925
SWOG S0925: A randomized phase 2 study of androgen deprivation combined with cixutumumab versus androgen deprivation alone in patients with new metastatic hormone-sensitive prostate cancer
- Journal / Conference
- Journal of Clinical Oncology Dec 1;33(34):4093-4098
- Year
- 2015
- Research Committee(s)
- Brain
- PMID
- PMID26527781
- PMC
- PMC4669593
- Study Number(s)
- SWOG-9005